Pharmacologically evoked apnoeas. Receptors and nervous pathways involved
Małgorzata Szereda-Przestaszewska1, Katarzyna Kaczyńska1
1Department of Respiration Physiology, Mossakowski Medical Research Centre Polish Academy of Sciences, A. Pawińskiego 5, 02-106 Warsaw, Poland.
Abstract:
This review analyses the knowledge about the incidence of transient apnoeic spells, induced by substances which activate vagal chemically sensitive afferents. It considers the specificity and expression of appropriate receptors, and relevant research on pontomedullary circuits contributing to a cessation of respiration. Insight is gained into an excitatory drive of 5-HT1A serotonin receptors in overcoming opioid-induced respiratory inhibition.
Insights
This review examines how substances activating vagal afferents cause transient apnoeic spells. It highlights the role of 5-HT1A serotonin receptors in reversing opioid-induced respiratory depression.
Area of Science:
- Neuroscience
- Respiratory Physiology
- Pharmacology
Background:
- Transient apnoeic spells can be triggered by chemical stimulation of vagal afferents.
- Understanding the neural circuits and receptors involved is crucial for managing respiratory dysfunction.
Purpose of the Study:
- To review the incidence of transient apnoeic spells induced by substances activating vagal chemically sensitive afferents.
- To explore the role of specific receptors and pontomedullary circuits in respiratory cessation.
- To investigate the potential of 5-HT1A serotonin receptors in counteracting opioid-induced respiratory inhibition.
Main Methods:
- Literature review of studies on vagal afferent stimulation and respiratory control.
- Analysis of research on pontomedullary respiratory circuits.
- Examination of receptor specificity and expression, particularly 5-HT1A receptors.
Main Results:
- Substances activating vagal chemically sensitive afferents can induce transient apnoeic spells.
- Pontomedullary circuits play a key role in the cessation of respiration.
- 5-HT1A serotonin receptors demonstrate an excitatory drive that can overcome opioid-induced respiratory inhibition.
Conclusions:
- Vagal afferent activation is a significant factor in transient apnoeic spells.
- Targeting 5-HT1A serotonin receptors offers a potential therapeutic strategy for opioid-induced respiratory depression.
Related Concept Videos
What is a Nervous System?
Insulin: The Receptor and Signaling Pathways
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
The Parasympathetic Nervous System
The Sympathetic Nervous System


